Cargando…

CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma

PURPOSE: Diffuse large B-cell lymphoma (DLBCL) is the most common B-cell malignancy. Thirty to forty percent of DLBCL patients still experience relapse or develop refractory disease even with standard immunochemotherapy, leading to a poor prognosis. Currently, although several gene-based classificat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jie, Zhu, Xiaoquan, Zhao, Yanyang, Zhou, Qi, Qi, Ruomei, Liu, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021264/ https://www.ncbi.nlm.nih.gov/pubmed/33833551 http://dx.doi.org/10.2147/PGPM.S301718

Ejemplares similares

Prophage-encoded gene VpaChn25_0734 amplifies ecological persistence of Vibrio parahaemolyticus CHN25
por: Xu, Yingwei, et al.
Publicado: (2022)

Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma
por: Wang, Feng, et al.
Publicado: (2008)

Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
por: Tzankov, Alexandar, et al.
Publicado: (2007)

Prophage-Related Gene VpaChn25_0724 Contributes to Cell Membrane Integrity and Growth of Vibrio parahaemolyticus CHN25
por: Yang, Lianzhi, et al.
Publicado: (2020)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Complete Genome Sequences of Two Porcine Deltacoronavirus Strains, CHN-GD16-03 and CHN-GD16-05, Isolated in Southern China, 2016
por: Mai, Kaijie, et al.
Publicado: (2018)

RAC1, a Potential Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma
por: Wu, Xue, et al.
Publicado: (2022)

Clinical Analysis and Prognostic Significance of Hepatitis B Virus Infections with Diffuse Large B-Cell Lymphoma
por: Kang, Xindan, et al.
Publicado: (2020)

Identification of a novel CHN1 p.(Phe213Val) variant in a large Han Chinese family with congenital Duane retraction syndrome
por: Zhou, Tai-Cheng, et al.
Publicado: (2020)

Prognostic implication of leucocyte subpopulations in diffuse large B-cell lymphoma
por: Han, Xiao, et al.
Publicado: (2017)

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma
por: Cao, Baoping, et al.
Publicado: (2021)

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
por: Liang, Xiao-jie, et al.
Publicado: (2022)

A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
por: Cen, Hong, et al.
Publicado: (2015)

A novel prognostic signature based on immune-related genes of diffuse large B-cell lymphoma
por: Wu, Zizheng, et al.
Publicado: (2021)

Prognostic role of pretreatment neutrophil-lymphocyte ratio in patients with diffuse large B-cell lymphoma treated with RCHOP
por: Wang, Jing, et al.
Publicado: (2016)

The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
por: Shen, Ziyuan, et al.
Publicado: (2022)

Preliminary study of hypoxia markers in diffuse large B-cell lymphoma
por: Pangarsa, Eko A., et al.
Publicado: (2022)

Inflammation marker ESR is effective in predicting outcome of diffuse large B-cell lymphoma
por: Wu, Shuang, et al.
Publicado: (2018)

International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
por: Mu, Shidai, et al.
Publicado: (2021)

A Novel Prognostic Model for Patients with Primary Gastric Diffuse Large B-Cell Lymphoma
por: Lu, Guangrong, et al.
Publicado: (2022)

Ginkgolide B inhibits platelet and monocyte adhesion in TNFα-treated HUVECs under laminar shear stress
por: Zhang, Ming, et al.
Publicado: (2018)

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
por: Sun, Yao, et al.
Publicado: (2016)

Novel prognostic genes of diffuse large B-cell lymphoma revealed by survival analysis of gene expression data
por: Li, Chenglong, et al.
Publicado: (2015)

Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
por: Pileri, Stefano A., et al.
Publicado: (2021)

A Prognostic Model of Gastrointestinal Diffuse Large B Cell Lymphoma
por: Gao, Fan, et al.
Publicado: (2021)

Genomic characterization and pathogenicity of porcine deltacoronavirus strain CHN-HG-2017 from China
por: Zhang, Meng-Jia, et al.
Publicado: (2018)

Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma
por: Cheng, Yuan, et al.
Publicado: (2019)

A modified prognostic model in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Contrast-Enhanced Ultrasound Parameters and D-Dimer: New Prognostic Parameters for Diffuse Large B-Cell Lymphoma
por: Duan, Shaobo, et al.
Publicado: (2022)

An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
por: Liang, Xiao-Jie, et al.
Publicado: (2021)

Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017)

Serine Protease 3 Promotes Progression of Diffuse Large B-Cell Lymphoma and Serves as a Novel Prognostic Predictor
por: Zheng, Liangda, et al.
Publicado: (2022)

Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma
por: Xu, Yongpeng, et al.
Publicado: (2022)

Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma
por: Xiong, Fei, et al.
Publicado: (2021)

Identification of three small nucleolar RNAs (snoRNAs) as potential prognostic markers in diffuse large B‐cell lymphoma
por: Li, Mei‐wei, et al.
Publicado: (2022)

Novel therapeutic targets in diffuse large B-cell lymphoma
por: Lenz, Georg
Publicado: (2013)

CCDC50, an essential driver involved in tumorigenesis, is a potential severity marker of diffuse large B cell lymphoma
por: Gong, Yuqi, et al.
Publicado: (2023)

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma
por: Chen, Guang-Liang, et al.
Publicado: (2022)

Prognostic impact of C-REL expression in diffuse large B-cell lymphoma
por: Curry, Choladda V, et al.
Publicado: (2009)

Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma
por: Bellas, Carmen, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_q3k6fl32bt6jqbfnfov2v5u5gs